| __timestamp | Amneal Pharmaceuticals, Inc. | CRISPR Therapeutics AG |
|---|---|---|
| Wednesday, January 1, 2014 | 106735000 | 1513000 |
| Thursday, January 1, 2015 | 136870000 | 12573000 |
| Friday, January 1, 2016 | 204747000 | 42238000 |
| Sunday, January 1, 2017 | 191938000 | 69800000 |
| Monday, January 1, 2018 | 210451000 | 113773000 |
| Tuesday, January 1, 2019 | 202287000 | 179362000 |
| Wednesday, January 1, 2020 | 190585000 | 266946000 |
| Friday, January 1, 2021 | 209563000 | 438633000 |
| Saturday, January 1, 2022 | 200046000 | 461645000 |
| Sunday, January 1, 2023 | 167778000 | 387332000 |
| Monday, January 1, 2024 | 320653000 |
Unleashing insights
In the ever-evolving landscape of biotechnology, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, Amneal Pharmaceuticals, Inc. and CRISPR Therapeutics AG have demonstrated contrasting strategies in their R&D investments.
From 2014 to 2023, Amneal Pharmaceuticals maintained a steady R&D expenditure, averaging around $182 million annually. However, CRISPR Therapeutics AG, a pioneer in gene-editing technology, exhibited a remarkable growth trajectory, with R&D spending surging by over 25,000% from 2014 to 2023. By 2022, CRISPR's R&D expenses were more than double those of Amneal, highlighting its aggressive pursuit of cutting-edge therapies.
This strategic focus on R&D underscores the dynamic nature of the biotech industry, where innovation is paramount. As these companies continue to invest in groundbreaking research, the future of healthcare looks promising.
Bristol-Myers Squibb Company or Amneal Pharmaceuticals, Inc.: Who Invests More in Innovation?
Analyzing R&D Budgets: Insmed Incorporated vs CRISPR Therapeutics AG
Analyzing R&D Budgets: Grifols, S.A. vs Amneal Pharmaceuticals, Inc.
Amneal Pharmaceuticals, Inc. or Ultragenyx Pharmaceutical Inc.: Who Invests More in Innovation?
Cost of Revenue Trends: Amneal Pharmaceuticals, Inc. vs CRISPR Therapeutics AG
Research and Development Expenses Breakdown: Amneal Pharmaceuticals, Inc. vs Geron Corporation
Analyzing R&D Budgets: Amneal Pharmaceuticals, Inc. vs Galapagos NV
Comparing Innovation Spending: CRISPR Therapeutics AG and Protagonist Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for CRISPR Therapeutics AG and Amphastar Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: CRISPR Therapeutics AG vs Mesoblast Limited
CRISPR Therapeutics AG vs Galapagos NV: Strategic Focus on R&D Spending
Research and Development Expenses Breakdown: CRISPR Therapeutics AG vs BioCryst Pharmaceuticals, Inc.